Europe, Middle East & Africa
Richer real world data drives smarter decisions.
Real world evidence is accelerating and informing almost every area of research and commercialization. IQVIA can help you analyze and understand the ever-expanding, global ecosystem of clinically-rich data in the context of your business.
800+ Million
Non-identified patient recordsHarness the power of Real World Data
Finding the right information for your study is critical but can be overwhelming and tedious. IQVIA makes it easier by bringing a combination of unparalleled clinically-rich data, advanced analytics and human knowledge throughout the clinical development pathway. Studies can start sooner. Drugs can get to market faster. Safety can be firmly established. All while privacy is protected.
Tap into our evidence ecosystem
IQVIA has an established network that includes hospitals, payers, pharmacies and associations. But we are deepening the richness of our information by accessing innovative data sources, including genomics data, wearables data, and patient reported outcomes.
This is constantly refreshed data from reliable sources all over the world. Connected data, part of an evidence ecosystem, is the new model for making smarter healthcare decisions that improve outcomes.
Technology is enabling RWE breakthroughs
Focus by therapeutic area or area of need
Comprehensive real world data on commercially insured patients in the US with a view into their diagnoses, treatments, and associated costs
Are you ready to meet healthcare stakeholders’ ever-increasing evidence demands?
Use emerging data sources and advances in evidence methods to demonstrate product value and safety.
Automate and customize data analysis and get the most out of your portfolio with scalable platforms.
Tap into evidence networks in oncology, neurology, immunology, and other therapy areas to enrich your studies.
Access clearer, more compelling support to demonstrate the value of your product.
From concept to market, we can meet your ever-increasing needs in regulatory, safety and compliance.